Live TheraSphere administration at World Congress on Interventional Oncology

322

Nordion has announced that organisers of the World Congress on Interventional Oncology (WCIO) 2012 hosted a live administration of the company’s TheraSphere Yttrium-90 (Y-90) glass microsphere liver cancer treatment.

The administration took place on Thursday, 14 June in the context of an approved Continuing Medical Education programme organised by the World Congress on Interventional Oncology (Chicago, USA, 14–17 June 2012).


The treatment was administered to a pre-screened patient at Northwestern Memorial Hospital (Northwestern University) in Chicago and broadcasted live via video link to physicians attending WCIO.


Real-time narration of the procedure was provided by Riad Salem, professor of Radiology, Medicine and Surgery and director, Interventional Oncology at Northwestern University, and one of the world’s experts in Y-90 radioembolization for liver cancer. 
Robert Lewandowski, associate professor, Radiology and his Northwestern University team(background in photo) performed the TheraSphere administration on a 62-year old hepatocellular carcinoma patient.

(Visited 18 times, 1 visits today)